Platinum Neurone Ventures (PNV) has been active since 2002 and is the result of the merger of the management teams of Platinum Ventures and Neurone Ventures I (1997) & II, Israel-based venture capital funds. PNV has $110 million under management and is headquartered in Tel-Aviv, Israel.
PNV mainly invests in later-stage and growth-stage companies in the fields of Communications, Information Technology, Semiconductor and Medical Device sectors. The fund is backed by global investors spearheaded by Bank of America, a world leading financial institution, Keppel T&T, a Singapore-based business logistics and telecommunications service provider, and the SFK Group, an Israel-based technology investment house.
At PNV, we provide value far beyond our capital. Our portfolio companies profit from an experienced management team that takes an active hands-on approach in building industry leading technology companies. We also provide our companies with operational expertise and access to our global contacts with leading telecommunications and semiconductor companies in Asia-Pacific and the US.
Preferred Investment Size and Stage
Our preferred investment size typically ranges from $1,000,000 to $4,000,000. The majority of our investments were carried out in the seed, first or second round stage, today we invest more in later stage and participate in follow-on rounds. PNV acts as lead investor in the majority of its investments, but also participates as a co-investor in select syndicated investments alongside leading venture capital funds.
|
 |
